The Role of Angiogenesis in the Development of Proliferative Diabetic Retinopathy: Impact of Intravitreal Anti-VEGF Treatment
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Role of Angiogenesis in the Development of Proliferative Diabetic Retinopathy: Impact of Intravitreal Anti-VEGF Treatment
Authors
Keywords
-
Journal
Experimental Diabetes Research
Volume 2012, Issue -, Pages 1-8
Publisher
Hindawi Limited
Online
2012-04-12
DOI
10.1155/2012/728325
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Treatment of proliferative diabetic retinopathy with anti-VEGF agents
- (2011) Aysha Salam et al. ACTA OPHTHALMOLOGICA
- A review of clinical trials of anti-VEGF agents for diabetic retinopathy
- (2010) Benjamin P. Nicholson et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Prevalence of Diabetic Retinopathy in the United States, 2005-2008
- (2010) Xinzhi Zhang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Repeated intravitreal bevacizumab (Avastin®) treatment of persistent new vessels in proliferative diabetic retinopathy after complete panretinal photocoagulation
- (2009) Gerald Schmidinger et al. ACTA OPHTHALMOLOGICA
- Efficacy and safety of one intravitreal injection of bevacizumab in diabetic macular oedema
- (2009) Vinod Kumar et al. ACTA OPHTHALMOLOGICA
- Observational Study of the Development of Diabetic Macular Edema Following Panretinal (Scatter) Photocoagulation Given in 1 or 4 Sittings
- (2009) ARCHIVES OF OPHTHALMOLOGY
- Intravitreal injection of pegaptanib sodium for proliferative diabetic retinopathy
- (2009) V H Gonzalez et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Intravitreal bevacizumab and aqueous shunting surgery for neovascular glaucoma: safety and efficacy
- (2009) Tarek M. Eid et al. CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE
- Rapid resolution of severe retinal neovascularisation in proliferative diabetic retinopathy following adjunctive intravitreal bevacizumab (Avastin)
- (2009) Michael Thew Clinical and Experimental Optometry
- Enlargement of the Foveal Avascular Zone in Diabetic Retinopathy After Adjunctive Intravitreal Bevacizumab (Avastin) With Pars Plana Vitrectomy
- (2009) Sung Jun Lee et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- Systemic Adverse Events after Bevacizumab
- (2009) Daniel B. Roth et al. OPHTHALMOLOGY
- Analysis of the Effect of Intravitreal Bevacizumab Injection on Diabetic Macular Edema after Cataract Surgery
- (2009) Yoshihiro Takamura et al. OPHTHALMOLOGY
- Intravitreal Bevacizumab for Prevention of Early Postvitrectomy Hemorrhage in Diabetic PatientsA Randomized Clinical Trial
- (2009) Hamid Ahmadieh et al. OPHTHALMOLOGY
- Role and Therapeutic Potential of VEGF in the Nervous System
- (2009) Carmen Ruiz de Almodovar et al. PHYSIOLOGICAL REVIEWS
- PREVENTION OF VISION LOSS AFTER CATARACT SURGERY IN DIABETIC MACULAR EDEMA WITH INTRAVITREAL BEVACIZUMAB
- (2009) AITOR LANZAGORTA-ARESTI et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- PANRETINAL PHOTOCOAGULATION COMBINED WITH INTRAVITREAL BEVACIZUMAB IN HIGH-RISK PROLIFERATIVE DIABETIC RETINOPATHY
- (2009) WON BIN CHO et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- BEVACIZUMAB PRETREATMENT IN VITRECTOMY WITH SILICONE OIL FOR SEVERE DIABETIC RETINOPATHY
- (2009) PO-TING YEH et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Review of Anti-VEGF Therapy in Proliferative Diabetic Retinopathy
- (2009) Maria Stephanie R. Jardeleza et al. Seminars in Ophthalmology
- Progression of tractional retinal detachment following intravitreal bevacizumab
- (2008) Jost B. Jonas et al. ACTA OPHTHALMOLOGICA
- Projection of Diabetic Retinopathy and Other Major Eye Diseases Among People With Diabetes Mellitus
- (2008) Jinan B. Saaddine ARCHIVES OF OPHTHALMOLOGY
- Intravitreal bevacizumab (Avastin®) injection for neovascular glaucoma: a survey on 23 cases throughout twelve-month follow-up
- (2008) Ciro Costagliola et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Pegaptanib sodium for neovascular age-related macular degeneration: third-year safety results of the VEGF Inhibition Study in Ocular Neovascularisation (VISION) trial
- (2008) L J Singerman et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Injection of intravitreal bevacizumab (Avastin) as a preoperative adjunct before vitrectomy surgery in the treatment of severe proliferative diabetic retinopathy (PDR)
- (2008) Stanislao Rizzo et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Intravitreal bevacizumab in active progressive proliferative diabetic retinopathy
- (2008) Siamak Moradian et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Role of combined cataract surgery and intravitreal bevacizumab injection in preventing progression of diabetic retinopathy
- (2008) Rizwan A. Cheema et al. JOURNAL OF CATARACT AND REFRACTIVE SURGERY
- The Wisconsin Epidemiologic Study of Diabetic Retinopathy XXII
- (2008) Ronald Klein et al. OPHTHALMOLOGY
- The Angio-Fibrotic Switch of VEGF and CTGF in Proliferative Diabetic Retinopathy
- (2008) Esther J. Kuiper et al. PLoS One
- INCIDENCE OF ACUTE ONSET ENDOPHTHALMITIS FOLLOWING INTRAVITREAL BEVACIZUMAB (AVASTIN) INJECTION
- (2008) JOHN O. MASON et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Intravitreal bevacizumab (Avastin®) in proliferative diabetic retinopathy
- (2007) Angelo M. Minnella et al. ACTA OPHTHALMOLOGICA
- Panretinal photocoagulation versus PRP plus intravitreal bevacizumab for high-risk proliferative diabetic retinopathy (IBeHi study)
- (2007) Matheus Tonello et al. ACTA OPHTHALMOLOGICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started